Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
50
ICL Quote, Financials, Valuation and Earnings
Last price:
$6.76
Seasonality move
:
3.23%
Day range:
$6.75 - $6.85
52-week range:
$3.79 - $7.35
Dividend yield:
2.71%
P/E ratio:
21.90x
P/S ratio:
1.27x
P/B ratio:
1.50x
Volume:
559.7K
Avg. volume:
779.4K
1-year change:
49.89%
Market cap:
$8.8B
Revenue:
$6.8B
EPS (TTM):
$0.31
Analysts' Opinion
-
Consensus RatingICL Group has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $6.74, ICL Group has an estimated downside of -0.77% from its current price of $6.79.
-
Price Target UpsideAccording to analysts, the highest upside price target is $7.00 representing -100% upside increase from its current price of $6.79.
Fair Value
-
According to the consensus of 4 analysts, ICL Group has -0.77% downside to fair value with a price target of $6.74 per share.
ICL vs. S&P 500
-
Over the past 5 trading days, ICL Group has underperformed the S&P 500 by -6.15% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
ICL Group does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
ICL Group has grown year-over-year revenues for 1 quarter straight. In the most recent quarter ICL Group reported revenues of $1.8B.
Earnings Growth
-
ICL Group earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter ICL Group reported earnings per share of $0.07.
Enterprise value:
11B
EV / Invested capital:
--
Price / LTM sales:
1.27x
EV / EBIT:
14.46x
EV / Revenue:
1.61x
PEG ratio (5yr expected):
--
EV / Free cash flow:
18.93x
Price / Operating cash flow:
15.03x
Enterprise value / EBITDA:
8.10x
Gross Profit (TTM):
$2.3B
Return On Assets:
3.4%
Net Income Margin (TTM):
5.66%
Return On Equity:
6.43%
Return On Invested Capital:
4.62%
Operating Margin:
10.47%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $9.6B | $7.2B | $6.9B | $1.7B | $1.8B | |
| Gross Profit | $4.6B | $2.4B | $2.3B | $557M | $560M | |
| Operating Income | $3B | $907M | $760M | $203M | $185M | |
| EBITDA | $3.6B | $1.4B | $1.4B | $375M | $361M | |
| Diluted EPS | $1.40 | $0.37 | $0.31 | $0.08 | $0.07 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $3B | $4.5B | $4.7B | $3.9B | $3.8B | |
| Total Assets | $9.7B | $11.7B | $12B | $11.5B | $11.7B | |
| Current Liabilities | $2.2B | $2.7B | $2.7B | $2.4B | $2.6B | |
| Total Liabilities | $5.6B | $6.3B | $6.1B | $5.4B | $5.6B | |
| Total Equity | $4.2B | $5.3B | $5.9B | $6B | $6.1B | |
| Total Debt | $2.7B | $2.9B | $3B | $2.5B | $2.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.2B | $1.6B | $1.3B | $292M | $165M | |
| Cash From Investing | -$844M | -$744M | -$791M | -$95M | -$192M | |
| Cash From Financing | -$1.2B | -$1B | -$592M | -$249M | $5M | |
| Free Cash Flow | $1.4B | $859M | $583M | $147M | -$25M | |
ICL
Sector
Market Cap
$8.8B
$19.1M
Price % of 52-Week High
92.38%
70.42%
Dividend Yield
2.71%
0%
Shareholder Yield
--
0.73%
1-Year Price Total Return
49.89%
-6.33%
Beta (5-Year)
1.156
0.736
Dividend yield:
2.71%
Annualized payout:
$0.19
Payout ratio:
62.21%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$7.01
200-day SMA
Buy
Level
$5.67
Bollinger Bands (100)
Buy
Level
6.02 - 6.88
Chaikin Money Flow
Buy
Level
53.4K
20-day SMA
Sell
Level
$6.92
Relative Strength Index (RSI14)
Sell
Level
46.82
ADX Line
Sell
Level
20
Williams %R
Buy
Level
-86.1538
50-day SMA
Buy
Level
$6.77
MACD (12, 26)
Buy
Level
1.89
25-day Aroon Oscillator
Buy
Level
52
On Balance Volume
Sell
Level
-2.9M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.3954)
Buy
CA Score
(Annual)
Level (0.0796)
Buy
Beneish M-Score
(Annual)
Level (-2.937)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.8076)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and innovative agriculture solutions (IAS). These segments all contribute to the company's development of agriculture, food, and engineered material products and services. The company mines and manufactures potash and phosphates to be used as ingredients in fertilizers and serve as a component in the pharmaceutical and food additives industries. It is also engaged in industrial additives and materials, including flame retardants, phosphate salts, specialty phosphate blends, purified phosphoric acid, electronic-grade specialty phosphoric acids. Its geographical segments are Europe, Asia, North & South America, and the Rest of the world.
Stock Forecast FAQ
In the current month, ICL has received 0 Buy ratings 4 Hold ratings, and 0 Sell ratings. The ICL average analyst price target in the past 3 months is $6.74.
-
Where Will ICL Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that ICL Group share price will drop to $6.74 per share over the next 12 months.
-
What Do Analysts Say About ICL Group?
Analysts are divided on their view about ICL Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that ICL Group is a Sell and believe this share price will rise from its current level to $6.20.
-
What Is ICL Group's Price Target?
The price target for ICL Group over the next 1-year time period is forecast to be $6.74 according to 4 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is ICL A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for ICL Group is a Hold. 4 of 4 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of ICL?
You can purchase shares of ICL Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase ICL Group shares.
-
What Is The ICL Group Share Price Today?
ICL Group was last trading at $6.76 per share. This represents the most recent stock quote for ICL Group. Yesterday, ICL Group closed at $6.79 per share.
-
How To Buy ICL Group Stock Online?
In order to purchase ICL Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
